Mono Mack Depot (Isosorbide Mononitrate)

Isosorbide Mononitrate, the active ingredient in Mono Mack Depot, is an organic nitrate presented as an oral dosage form for oral use. It is used to manage chronic stable angina and to help prevent angina attacks in adult patients under medical supervision.

GNH USA supplies Mono Mack Depot as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides regulatory documentation for importers, including batch release certificates and stability data.

Isosorbide Mononitrate is an oral nitrate that reduces myocardial oxygen demand in patients with angina.

Chronic stable angina: reduces the frequency of angina episodes and improves exercise tolerance. Prevention of angina attacks: provides prophylactic control of chest pain during physical activity. Angina pectoris: alleviates symptomatic chest discomfort associated with coronary artery disease.

Isosorbide mononitrate may cause a range of adverse reactions, which are generally classified by frequency.

Common Side Effects: - Headache - Dizziness - Flushing - Nausea

Serious or Rare Side Effects: - Severe hypotension - Syncope - Methemoglobinemia (rare)

When prescribing isosorbide mononitrate, clinicians should consider several safety measures.

Monitor blood pressure: check for hypotension especially after the first dose. Avoid concurrent use with phosphodiesterase‑5 inhibitors: risk of profound vasodilation. Adjust dose in hepatic impairment: use caution and consider lower starting dose. Counsel patients on orthostatic dizziness: advise rising slowly from sitting or lying positions. Store at ambient temperature: keep in the original container, protect from moisture and light.

Isosorbide mononitrate interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Other nitrates (e.g., nitroglycerin): additive vasodilatory effect leading to severe hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): risk of profound blood pressure drop.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (beta‑blockers, ACE inhibitors): may enhance blood‑pressure‑lowering effect. - Diuretics: can increase the likelihood of orthostatic hypotension. - Alcohol and smoking: alcohol may worsen hypotension; smoking accelerates nitrate metabolism, reducing efficacy.